PIK3CA and colonic neoplasm: In our study, 80% of the PDX models were genomically concordant with the primary colon tumors, and 1 PDX model (ID 30306113) demonstrated a newly emerged PIK3CA oncogenic mutation (E542K) with allelic frequency of 49%.